Hillary Handler

An authority in the field of neuroscience, Dr. Hillary Handler has made significant strides in understanding neurodegenerative diseases. She completed her Ph.D. in 2022 through the Graduate Program in Neuroscience at the University of Minnesota. Her doctoral research was centered on Spinocerebellar ataxia type 1 (SCA1), where she explored innovative approaches to disrupt the nuclear localization of Expanded ATXN1. This work aimed to alleviate SCA1 phenotypes and address transcriptomic perturbations, contributing valuable insights into this complex neurodegenerative condition. Currently, Dr. Handler applies her expertise as a Genetic Counselor at MHealth/Fairview, where she continues to bridge the gap between research and clinical practice. Her role involves providing genetic counseling services, which are crucial for patients and families navigating the challenges of genetic disorders. Her work is informed by her deep understanding of the genetic underpinnings of neurodegenerative diseases, making her a vital resource in her field. Dr. Handler's research interests are diverse and encompass Computational Neuroscience, Neurodegenerative Diseases, Neural Injury, and Neurogenetics. Her passion for these areas is reflected in her graduate publications, which have significantly advanced the scientific community's understanding of SCA1. Under the mentorship of her Graduate Advisor, Harry T. Orr, she honed her research skills and developed a keen interest in the intricate mechanisms underlying neurodegenerative diseases. Her contributions to the field have not only enhanced the scientific understanding of SCA1 but have also paved the way for potential therapeutic interventions. Dr. Handler's work exemplifies the integration of computational approaches with traditional neuroscience, offering new perspectives on tackling complex neurological disorders. As she continues her career, Dr. Handler remains committed to advancing the field of neuroscience through both research and clinical practice. Her dedication to improving patient outcomes and her innovative approach to research make her a respected figure in the scientific community.